三生国健：关于收到参股公司分红款的公告

Core Viewpoint - Sanofi announced a dividend of $8.8756 million from its stake in Numab Therapeutics, which will positively impact the company's financial performance in 2025 [2] Group 1 - The company holds a 5.48% stake in Numab Therapeutics [2] - The dividend received will be accounted for in the company's 2025 financial results [2] - The dividend is expected to have a positive effect on the company's operating performance for the fiscal year 2025 [2]